Carolyn Edelstein

What if we could fight antibiotic resistance with bacteria?

Apply to Attend TEDMED 2017
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 1 - 3, 2017.
Apply Today!

Have a suggestion for The Hive?
Submit a Nomination Today

Share This Talk

About Carolyn Edelstein

As the Director of Policy and Global Partnerships at OpenBiome, Carolyn Edelstein oversees OpenBiome's efforts to expand the availability of Fecal Microbiota Transplantation overseas, present its work to the public, and contribute to the discourse on the regulation of fecal microbiota. Her work on the subject has appeared in Nature Biotechnology, the Journal of the Law and the Biosciences, and Clinical Research and Regulatory Affairs. Previously, Carolyn worked at the US Agency for International Development, and helped launch the Global Innovation Fund, a $200 million platform to test and support low-cost, high-impact interventions to improve global health and prosperity. She holds an MPA and a BA from Princeton University's Woodrow Wilson School of Public and International Affairs.

About This Idea

With the rise of antibiotic resistance, the search is on for therapies that can combat bacterial infections without engaging in an evolutionary arms race. OpenBiome is a nonprofit stool bank that aims to expand safe access to fecal transplantation for patients with recurrent C. difficile and to catalyze research on the microbiome’s role in human health. OpenBiome provides clinicians with rigorously screened, ready-to-use stool preparations and supports researchers with a suite of tools to discover how gut bacteria might treat diseases beyond C. difficile. Since 2013, OpenBiome has partnered with over 700 healthcare institutions across all 50 states and 6 countries to deliver over 14,000 treatments for recurrent C. difficile. Its portfolio includes 50% of all U.S. trials exploring the use of fecal transplants in new diseases.

Other Hive Talks